News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Redpoint Bio Corporation (RPBC) Signs Pharmaceutical Research Agreement with Schering Corporation



11/13/2008 10:38:11 AM

EWING, N.J.--(BUSINESS WIRE)--Redpoint Bio Corporation (OTCBB: RPBC), a company developing products and technologies to improve the taste of pharmaceutical, food and beverage products, today announced that it has signed an agreement to collaborate with Schering Corporation, a subsidiary of Schering-Plough Corporation (NYSE: SGP), in the area of taste science research for pharmaceutical applications. This expanded feasibility agreement builds upon the successful completion of a previous research study between the parties. Scope and terms of the agreement were not disclosed.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES